Clinical Trials Logo

Varicella clinical trials

View clinical trials related to Varicella.

Filter by:

NCT ID: NCT00226499 Completed - Varicella Clinical Trials

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Start date: September 1, 2005
Phase: Phase 3
Study type: Interventional

An observer-blind study to evaluate GlaxoSmithKline Biologicals' live attenuated varicella vaccine and GlaxoSmithKline Biologicals' combined measles-mumps-rubella-varicella vaccine in the prevention of varicella disease in children. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

NCT ID: NCT00169416 Completed - Varicella Clinical Trials

Evaluation Of Valaciclovir In Patients With Chickenpox

Start date: March 2005
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy, and the pharmacokinetics of aciclovir and valaciclovir in children with chickenpox following oral administration of valaciclovir, for the purpose of seeking approval of valaciclovir HCl for the treatment of chickenpox.

NCT ID: NCT00138255 Terminated - Measles Clinical Trials

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Start date: June 2004
Phase: Phase 4
Study type: Observational

The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.

NCT ID: NCT00127608 Completed - Varicella Clinical Trials

Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

Start date: June 7, 2005
Phase: Phase 3
Study type: Interventional

This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about chickenpox disease.

NCT ID: NCT00127023 Completed - Measles Clinical Trials

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: May 2005
Phase: Phase 3
Study type: Interventional

This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.

NCT ID: NCT00127010 Completed - Measles Clinical Trials

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: November 2005
Phase: Phase 3
Study type: Interventional

This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.

NCT ID: NCT00126997 Completed - Measles Clinical Trials

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: May 2005
Phase: Phase 4
Study type: Interventional

This is a study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals live attenuated measles-mumps-rubella-varicella vaccine given to healthy children in their second year of life.

NCT ID: NCT00109343 Completed - Measles Clinical Trials

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The study is being conducted to demonstrate that V221 may be administered concomitantly with pneumococcal conjugate vaccine without impairing the safety or immunogenicity of measles, mumps, rubella, varicella, or the 7 serotypes of S. pneumoniae.

NCT ID: NCT00092430 Completed - Measles Clinical Trials

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Start date: September 26, 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.

NCT ID: NCT00092404 Completed - Measles Clinical Trials

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Start date: December 2001
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to study the safety and immune response to measles, mumps, and rubella in children who were vaccinated with an investigational measles-mumps-rubella live vaccine made with artificially made human protein.